Health-related quality of life measurements and studies in rheumatoid arthritis

American Journal of Managed Care

Volumn 8, Issue 9, 2002, Pages 811-820

  Lubeck, Deborah P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AUROTHIOMALATE; ETANERCEPT; GOLD; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PLACEBO; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADMINISTRATIVE PERSONNEL; ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISEASE COURSE; DOCTOR PATIENT RELATION; DRUG EFFECT; DRUG EFFICACY; FINANCIAL MANAGEMENT; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; MANAGED CARE; MEDICAL DECISION MAKING; PREFERRED PROVIDER ORGANIZATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REIMBURSEMENT; RHEUMATOID ARTHRITIS; SELF EVALUATION; SELF EXAMINATION; UNITED STATES; WELLBEING;

ACTIVITIES OF DAILY LIVING; ARTHRITIS, RHEUMATOID; COST-BENEFIT ANALYSIS; FORMULARIES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MANAGED CARE PROGRAMS; QUALITY OF LIFE; QUESTIONNAIRES; SELF EFFICACY; SICKNESS IMPACT PROFILE; UNITED STATES;

EID: 0036732278     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Rheumatoid arthritis
2. Adult and juvenile rheumatoid arthritis: Current epidemiologic concepts
3. The impact of rheumatoid arthritis on the household work performance of women
4. Work disability and the experience of pain and depression in rheumatoid arthritis
5. The mortality of rheumatoid arthritis
6. The work dynamics of the person with rheumatoid arthritis
7. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls
8. Indirect medical costs of rheumatoid arthritis: Development within the first three years after onset
9. Guidelines for the management of rheumatoid arthritis
10. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial
11. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): Analyses in 2491 rheumatoid arthritis patients following leflunomide initiation
12. Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis
13. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures
14. Health status as a predictor of mortality in rheumatoid arthritis: A five-year study
15. Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis
16. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
17. Risk factors for hospitalization and surgery in patients with rheumatoid arthritis: Implications for capitated medical payment
18. The assessment and prediction of functional disability in rheumatoid arthritis
19. Standard self-report questionnaire in routine clinical and research practice - An opportunity for patients and rheumatologists
20. Lack of congruence in the ratings of patients' health status by patients and their physicians
21. The health assessment questionnaire 1992: Status and review
22. Health status questionnaires
23. Practical issues in psychosocial measures
24. Measuring health status and outcomes in rheumatoid arthritis within routine clinical practice
25. Sensitivity to change of the Health Assessment Questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: Results of short-term clinical trials and observational studies versus long-term observational studies
26. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
27. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
28. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection
29. The SF-36 Arthritis-Specific Health Index (ASHI): II. Tests of validity in four clinical trials
30. Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo
31. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales
32. Relationship between self-rated functional status and psychosocial stress in patients suffering from rheumatoid arthritis
33. Joint impairment is strongly correlated with disability measured by self-report questionnaires. Functional status assessment of individuals with rheumatoid arthritis in a population based series
34. The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients
35. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial
36. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: Results of a five year prospective study
37. a - A pivotal role in rheumatoid arthritis?
38. Etanercept therapy in rheumatoid arthritis: A randomized, controlled trial
39. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
40. Infliximab improves long-term quality of life and functional status in patients with rheumatoid arthritis
41. Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis
42. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
43. Leflunomide improves quality of life in rheumatoid arthritis
44. Adding leflunomide (LEF) to patients with active rheumatoid arthritis (RA) while receiving methotrexate (MTX) improves physical function and health-related quality of life (HRQOL)
45. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
46. Infliximab and methotrexate in the treatment of rheumatoid arthritis
47. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis
48. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
49. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial
50. Examination of aggreement between HAQ and MHAQ in patients with rheumatoid arthritis
51. Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis
52. The psychosocial and clinical status of younger women with early rheumatoid arthritis: A longitudinal study with frequent measures
53. The AIMS2-SF: A short form of the Arthritis Impact Measurement Scales 2
54. A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1000 rheumatoid arthritis patients
55. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
56. Health outcomes. New quality measure for Medicare
57. Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis
58. Measuring health status in British patients with rheumatoid arthritis: Reliability, validity and responsiveness of the short form 36-item health survey (SF-36)
59. How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study
60. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures
61. Finding health-related quality of life outcomes sensitive to health-care organization and delivery
62. The SF-36 Arthritis-Specific Health Index (ASHI): I. Development and cross-validation of scoring algorithms
63. Monitoring health outcomes among patients with arthritis using the SF-36 Health Survey: Overview
64. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis
65. Generic and disease-specific measures in assessing health status and quality of life